forodesine hydrochloride (BioCryst Inc)
Structured Review
Forodesine Hydrochloride, supplied by BioCryst Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/forodesine+hydrochloride/forodesine/pm37801827-346-16-13
Average 90 stars, based on 1 article reviews
Images
Related Articles
Clinical Proteomics:Article Title: Hydroxyl-related differences for three dietary flavonoids as inhibitors of human purine nucleoside phosphorylase. Article Snippet: Hydroxyl-related differences for three dietary flavonoids as inhibitors of human purine nucleoside phosphorylase Control:Article Title: Hydroxyl-related differences for three dietary flavonoids as inhibitors of human purine nucleoside phosphorylase. Article Snippet: Hydroxyl-related differences for three dietary flavonoids as inhibitors of human purine nucleoside phosphorylase other:Article Title: Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma. Article Snippet: Purine nucleoside phosphorylase (PNP) deficiency is a rare, inherited immunodeficiency disorder in which the specific molecular defect was identified.. Clinically, a lack of PNP manifests as profound T-cell deficiency with minor or variable changes in the humoral system.. Biochemically, the absence of PNP results in an increase in plasma deoxyguanosine (dGuo) and a T-cell-specific increase in intracellular deoxyguanosine triphosphate (dGTP). Article Title: New nucleoside analogs for patients with hematological malignancies. Article Snippet: Introduction: In the last few years, several new purine and pyrimidine nucleoside analogs have been synthesized and made available for both preclinical studies and clinical trials.. Areas covered: This article summarizes recent achievements in the mechanism of action, pharmacological properties and clinical activity and toxicity as well as the emerging role of newer purine and pyrimidine nucleoside analogs potentially active in lymphoid and myeloid malignancies.. A literature review was conducted from the MEDLINE database PubMed for articles in English. |

